文献速递妇科

上腹下丛神经阻滞在微创妇科手术中的随机对照试验

Superior Hypogastric Plexus Nerve Block in Minimally Invasive Gynecology: A Randomized Controlled Trial.
PubMed 文献 · J Minim Invasive Gynecol · 2021-06-29

本研究为患者盲法随机对照试验,纳入56例拟行腹腔镜或机器人辅助腹腔镜子宫切除术或子宫肌瘤剔除术的良性指征患者,比较罗哌卡因上腹下丛神经阻滞与无阻滞对术后24小时阿片类药物用量(吗啡毫克当量,MME)的影响。

要点

  • 上腹下丛神经阻滞可减少微创妇科手术后24小时阿片类药物用量约38%。
  • 阻滞组术后24小时疼痛评分较对照组更低(1.8 vs 2.6)。
  • 未见局部麻醉药毒性、神经损伤或肠管/血管损伤等不良事件。

核心结论

  • 上腹下丛神经阻滞是一种简单技术,可减少微创妇科手术后24小时阿片类药物需求量和疼痛。

研究设计与样本

  • 患者盲法随机对照试验,单中心学术机构(悉尼女性内镜手术中心),由两名外科医生在其各自手术中实施阻滞。
  • 纳入对象为因良性指征行腹腔镜或机器人辅助腹腔镜子宫切除术或子宫肌瘤剔除术的患者。

主要发现

  • 阻滞组平均阿片类药物用量为33.1 MME(95%CI 24.2-41.9),对照组为54.9 MME(95%CI 40.7-69.1)。
  • 阻滞组阿片类药物用量范围为1.0至76.5 MME,四分位距为37(14-51);对照组范围为7.5至113.5 MME,四分位距为60(28-88)。
  • 术后24小时疼痛评分(视觉模拟量表1-10分)配对比较:阻滞组平均1.8(95%CI 1.5-2.1),对照组2.6(95%CI 2.3-2.9)。
  • 未见局部麻醉药毒性、神经损伤或肠管/血管损伤等不良事件。

关键数值与推荐

  • 干预措施:罗哌卡因10 mL(0.75%)浸润至覆盖上腹下丛的腹膜后间隙,对照组不给阻滞。
  • 所有患者均使用标准化芬太尼患者自控镇痛。
  • 主要结局为术后24小时总阿片类药物用量(MME);次要结局为术后1、2、6、12和24小时视觉模拟量表(1-10分)疼痛评分。

临床怎么用

  • 在微创妇科手术(腹腔镜或机器人辅助腹腔镜子宫切除术或子宫肌瘤剔除术)完成时,可考虑行上腹下丛神经阻滞以降低术后24小时阿片类药物用量和疼痛。
  • 该技术简单,未见局部麻醉药毒性、神经损伤或肠管/血管损伤等不良事件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To assess the efficacy of a superior hypogastric plexus nerve block in reducing opioid requirements in the first 24 hours after minimally invasive gynecologic surgery. DESIGN: Patient-blinded randomized controlled trial. SETTING: Single-center academic institution (Sydney Women's Endosurgery Centre). Two surgeons administering the blocks in their own surgeries. PATIENTS: Patients undergoing either laparoscopic or robot-assisted laparoscopic hysterectomy or myomectomy for benign indications. INTERVENTIONS: Ropivacaine 10 mL (0.75%) infiltrated into the retroperitoneal space overlying the superior hypogastric plexus vs control of no block given at the completion of surgery. MEASUREMENTS AND MAIN RESULTS: The primary outcome was the total opioid use in the first 24 hours after surgery, measured in morphine milligram equivalents (MME). Standardized fentanyl patient-controlled analgesia was given to all patients in the trial. The secondary outcome was pain measured on a visual analog scale (1 to 10) at 1, 2, 6, 12, and 24 hours after surgery. Fifty patients out of 56 approached for the study participated in, and completed, the study (89.2%). The patients were randomized over a 5-month period, March 2020 to July 2020. A total of 27 patients were randomized to receive a nerve block, and 23 were randomized to the control. There was a difference of -21.8 MME in the block group compared with the no-block group (95% confidence interval [CI], -38.2 to -5.5; p = .008). This correlated to a 38% reduction in opioid use in the block group. The mean opioid use in the patients in the block group was 33.1 MME (95% CI, 24.2-41.9) and in those in the no-block group 54.9 MME (95% CI, 40.7-69.1). For the block group, opioid use ranged from 1.0 to 76.5 MME, with an interquartile range of 37 (14-51). For the control group, the range was 7.5 to 113.5 MME, with a higher interquartile range of 60 (28-88). Pairwise comparisons of the mean pain scores over the 24 hours showed a lower pain score with a nerve block of 1.8 (95% CI, 1.5-2.1) compared with a no-block score of 2.6 (95% CI, 2.3-2.9) No adverse effects of local anesthetic toxicity, nerve injury, or bowel/vascular injury were noted in any patient. CONCLUSION: A superior hypogastric plexus nerve block is a simple technique for reducing postoperative opioid requirements and pain in the first 24 hours after minimally invasive gynecologic surgery.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. De Silva P, Daniels S, Bukhari ME, et al. Superior Hypogastric Plexus Nerve Block in Minimally Invasive Gynecology: A Randomized Controlled Trial. J Minim Invasive Gynecol. 2021. PMID: 34197956. doi:10.1016/j.jmig.2021.06.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。